Logo
O

OneChain Immunotherapeutics

9 employees

OCI develops therapies for leukaemia based on CAR–T.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
CARTs
Inmunoterapia
Life Science
Leucemia
Medicina Personalizada
Innovación
Biotecnología
Hematología
Biomedicina
Investigación

Date founded

2020

Funding rounds raised

Total raised

$7.4M

from 5 investors over 5 rounds

O

OneChain Immunotherapeutics raised $7.4M on June 22, 2023

Investors: Clave Capital, Nara Capital, Josep Carreras Leukaemia Research Institute and CDTI, Centre for the Development of Industrial Technology

O

OneChain Immunotherapeutics raised $3.6M on July 27, 2020

Investors: Josep Carreras Leukaemia Research Institute

FAQ